Ordinary Medicine: Extraordinary Treatments, Longer Lives and Where to Draw the Line
Research Notes of her book by Dr. Sharon Kaufman
この書籍の紹介
"Most of us want and
expect medicine’s miracles to extend our lives. In today’s aging
society, however, the line between life-giving therapies and too much
treatment is hard to see—it’s being obscured by a perfect storm created
by the pharmaceutical and biomedical industries, along with insurance
companies. In Ordinary Medicine Sharon R. Kaufman investigates what
drives that storm’s “more is better” approach to medicine: a nearly
invisible chain of social, economic, and bureaucratic forces that has
made once-extraordinary treatments seem ordinary, necessary, and
desirable. Since 2002 Kaufman has listened to hundreds of older
patients, their physicians and family members express their hopes,
fears, and reasoning as they faced the line between enough and too much
intervention. Their stories anchor Ordinary Medicine. Today’s medicine,
Kaufman contends, shapes nearly every American’s experience of growing
older, and ultimately medicine is undermining its own ability to
function as a social good. Kaufman’s careful mapping of the sources of
our health care dilemmas should make it far easier to rethink and renew
medicine’s goals."
章立てである
Acknowledgments
Introduction
Diagnosing Twenty -First-Century Health Care
PART I: THE QUANDARY AND UNEXAMINED ORDINARINESS OF TWENTY-FIRST-CENTURY MEDICINE
1. Ordinary Medicine in Our Aging Society: The Dilemma of Longevity
PART II: THE CHAIN OF HEALTH CARE DRIVERS
2. The Medical-Industrial Complex I: Evidence -Based Medicine, the Biomedical Economy, and the Ascendance of Clinical Trials
3. The Medical-Industrial Complex II: Access, Industry, and the Clinical Trials Phenomenon
4. "Reimbursement Is Critical for Everything": Medicare and the Ethics of Managing Life
PART Ill: MEDICINE'S CHANGING MEANS AND ENDS
5. Standard and Necessary Treatments: The Changing Means and Ends of Technology
6. Family Matters: Kidneys and New Forms of Care
7. Influencing the Character of the Future Prognosis, Risk, and Time Left
8. For Whose Benefit? Our Shared Quandary
Conclusion
Toward a New Social Contract?
Notes on the Research
Notes
Bibliography
Index
この本について、シャロン・カウフマン名誉教授がこの著作について 語っているのでご参考までに......
■Where is the line between 'enough' and 'too much' treatment? That is the topic of Sharon Kaufman's book that explores how any technology or practice that prevents death became the ordinary standard of care. She and palliative care doctor Dawn Gross discuss how improving technologies for extending life intensify debates about the issues surrounding aging and dying. Recorded on 05/25/2017. (#32348)
リンク
文献
その他の情報